News Breaks |
|
|
| October 26, 2012 |
| 10:00 EDT |  | AB, PG, ACAT, TGT, PSX, OI, STEL, MYL, HBAN, EXPE, CME, LAZ | On The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: AllianceBernstein (AB) upgraded to Equal Weight from Underweight at Morgan Stanley... CME Group (CME) upgraded to Outperform from Market Perform at Raymond James... Expedia (EXPE) upgraded to Buy from Hold at Benchmark Co.... Expedia (EXPE) upgraded to Outperform from Market Perform at Raymond James... Huntington Bancshares (HBAN) upgraded to Buy from Neutral at Citigroup... Mylan (MYL) upgraded to Buy from Hold at Canaccord... StellarOne (STEL) upgraded to Strong Buy from Outperform at Raymond James... Owens-Illinois (OI) upgraded to Buy from Neutral at BofA/Merrill... Phillips 66 (PSX) upgraded to Outperform from Neutral at Credit Suisse... Target (TGT) upgraded to Buy from Neutral at Buckingham... Arctic Cat (ACAT) upgraded to Strong Buy from Buy at Felti... Proctor and Gamble (PG) upgraded to Outperform from Underperform at CLSA... Lazard (LAZ) upgraded to Neutral from Sell at Rochdale. |
|
|
News For AB;CME;EXPE;HBAN;MYL;STEL;OI;PSX;TGT;ACAT;PG;LAZ From The Last 14 Days Check below for free stories on AB;CME;EXPE;HBAN;MYL;STEL;OI;PSX;TGT;ACAT;PG;LAZ the last two weeks. |
|
|
| June 19, 2013 |
| 11:01 EDT |  | PG | Procter & Gamble announces fragrance license agreement with Alexander McQueen
 Subscribe for More Information |
|
| 08:08 EDT |  | EXPE | Data bodes well for Expedia Q2 results, says Cantor
Cantor believes that various data points, including strong April and May paid click volume growth on Expedia.com in April and May, bode well for the company's Q2 results. The firm keeps a $75 price target and Buy rating on the shares. |
|
| 07:51 EDT |  | MYL | EC fines Ranbaxy, others for blocking cheaper drugs, Economic Times reports
Subscribe for More Information |
|
| 07:10 EDT | | CME | High-frequency firms in merger talks, WSJ reports
Subscribe for More Information |
|
| June 18, 2013 |
| 08:36 EDT | | MYL | Elan shares could be worh $19 in a buyout, says Jefferies
Jefferies raised its price target for shares of Elan (ELN) to $19 from $14, reflecting what it sees as the value of the company in a takeout scenario. The firm says Elan management suggested they would be open to sale in the $15-$20 per share range. Jefferies believes a high taxpaying suitor could pay the upper end of that range, and lists Allergan (AGN), Regeneron (REGN), Vertex (VRTX), Alexion (ALXN), Zoetis (ZTS), Mylan (MYL) and Perrigo (PRGO) as potential acquirers for Elan. Shares of Elan are up 13c to $13.62 in pre-market trading after Royalty Pharma announced that its buyout proposal for the company has expired. |
|
| June 17, 2013 |
| 13:20 EDT | | MYL | Supreme Court rules generic drug makers can be sued over 'pay to delay'
Subscribe for More Information |
|
| 11:54 EDT | | MYL | Supreme Court ruling a modest negative for generics, says Leerink
Subscribe for More Information |
|
| 09:11 EDT | | CME | CME Group price target raised to $85 from $70 at Bernstein
Subscribe for More Information |
|
| 08:36 EDT | | MYL | InSite Vision to join Merck, Pfizer patent suit against Mylan
InSite Vision (INSV) announced that it will join Merck (MRK) and Pfizer (PFE) in filing a patent infringement lawsuit against Mylan Pharmaceuticals (MYL). Mylan recently filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration seeking to market a generic version of AzaSite before expiration of the patents covering AzaSite and its use. AzaSite is marketed by Merck in the U.S. On May 26, 2011, InSite and Merck filed a similar patent infringement lawsuit against Sandoz. A trial date for the Sandoz ANDA suit has been set for July 11, 2013. The companies have agreed that Merck will take the lead in prosecuting both lawsuits. Each company will be responsible for their own legal costs, with InSite assuming a monitoring role, the company said. |
|
| 08:35 EDT | | PSX | DCP Midstream, Phillips 66, Spectra Energy announce NGL pipelines in service
Subscribe for More Information |
| |
| 07:22 EDT |  | PG | Biotech Industry Organization to host a conference
Subscribe for More Information |
|
| June 14, 2013 |
| 10:10 EDT | | CME | On The Fly: Analyst Upgrade Summary
Subscribe for More Information |
|
| 07:35 EDT | | TGT | Sears cuts two Canadian stores near Toronto, Globe and Mail reports
Sears Canada (SHLD) is selling leases of two of its high-profile stores back to their landlords for $191M plus options on a third store for $1M that could raise another $53M within five years, reports the Globe and Mail. The moves come as Sears races to revive its struggling business amid intensifying competition in Canada and the arrival of Target (TGT), which started to open its first stores here in March, and Nordstrom (JWN), which launches in Canada next year.Reference Link |
|
| 07:21 EDT | | TGT | Clinton Global Initiative to host to host a meeting
Subscribe for More Information |
|
| 07:00 EDT | | CME | CME Group upgraded to Buy from Neutral at ISI Group
|
|
| June 13, 2013 |
| 17:23 EDT |  | MYL | Mylan files automatic mixed securities shelf
Subscribe for More Information |
|
| 10:05 EDT |  | STEL | On The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: AngloGold (AU) downgraded to Sell from Hold at Societe Generale... Banco Santander (SAN) downgraded to Underweight from Neutral at JPMorgan... Cosi (COSI) downgraded to Neutral from Buy at Roth Capital... Randgold Resources (GOLD) downgraded to Hold from Buy at Societe Generale... Republic Services (RSG) downgraded to Buy from Conviction Buy at Goldman... Royal Bank of Scotland (RBS) downgraded to Sell from Hold at Deutsche Bank... Safeway (SWY) downgraded to Neutral from Buy at Citigroup... Smithfield Foods (SFD) downgraded to Neutral from Buy at Davenport... Vantage Drilling (VTG) downgraded to Market Perform from Outperform at Wells Fargo... Waste Management (WM) downgraded to Neutral from Buy at Goldman... Lexington Realty (LXP) downgraded to Underweight from Hold at KeyBanc... EPR Properties (EPR) downgraded to Underweight from Hold at KeyBancMedical Properties Trust (MPW) downgraded to Underweight from Hold at KeyBanc... Ventas (VTR) downgraded to Underweight from Hold at KeyBanc... Health Care REIT (HCN) downgraded to Hold from Buy at KeyBanc... StellarOne (STEL) downgraded to Market Perform from Strong Buy at Raymond James... Polypore (PPO) downgraded to Hold from Buy at Topeka. |
|
| 09:30 EDT | | TGT | Clinton Global Initiative to host to host a meeting
Subscribe for More Information |
|
| 07:46 EDT | | STEL | StellarOne downgraded to Market Perform from Strong Buy at Raymond James
Subscribe for More Information |
|
| 07:09 EDT | | PG | Procter & Gamble reviews its guidance, WSJ reports
Subscribe for More Information |
| |
|
|
|
|
